20-F/A XBRL

AMENDMENT NO. 1 TO FORM 20-F

Company: XTL BIOPHARMACEUTICALS LTD
Filed: May 19, 2021
Period of Report: December 31, 2020
Accession Number: 0001213900-21-027792

View Document ↗ View on SEC.gov ↗